betamethasone-17,21-dipropionate has been researched along with Cushing's Syndrome in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| López-Ruz, MÁ; Rosales-Castillo, A | 1 |
| Aberer, W; Böckle, BC; Jara, D; Nindl, W; Sepp, NT | 1 |
| Besson-Léaud, M; Dandine, M; Lavaud, J; Limal, JM | 1 |
| Moriello, KA; Ridgway, HB | 1 |
4 other study(ies) available for betamethasone-17,21-dipropionate and Cushing's Syndrome
| Article | Year |
|---|---|
Cushing's syndrome due to interaction between topical betamethasone dipropionate and darunavir/cobicistat.
Topics: Betamethasone; Cobicistat; Cushing Syndrome; Darunavir; Humans | 2020 |
Adrenal insufficiency as a result of long-term misuse of topical corticosteroids.
Topics: Administration, Cutaneous; Adrenal Insufficiency; Adult; Betamethasone; Chronic Disease; Cushing Syndrome; Dermatitis, Atopic; Glucocorticoids; Humans; Male; Psoriasis; Self Medication; Time Factors; Young Adult | 2014 |
[Adrenal insufficiency and iatrogenic Cushing's syndrome by cutaneous absorption of corticosteroids in an 8 month old infant].
Topics: Adrenal Insufficiency; Betamethasone; Cushing Syndrome; Erythema; Female; Humans; Hydrocortisone; Iatrogenic Disease; Infant; Skin Absorption | 1980 |
Iatrogenic Cushing's syndrome in a dog from owner's topical corticosteroid.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Betamethasone; Cushing Syndrome; Dog Diseases; Dogs; Glucocorticoids | 1993 |